Biovail Pharmaceuticals fired Kasowitz, Benson, Torres & Friedman on Friday from its high-profile case against several hedge funds and Wall Street analysts, as questions continued over whether the law firm knowingly used documents covered by a protective order to help bring the suit.
“Due to issues arising from proceedings before Judge [Richard] Owen, Biovail has terminated its relationship with the Kasowitz firm,” the company said through a spokesman. Kasowitz Benson says it has done nothing wrong in the case, and issued a statement saying the firm had performed “outstanding legal work for Biovail at all times.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]